Metraipolis › archive › dc_d1e00fb8e899
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42435328
- DOI
- 10.1002/ueg2.70258
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T14:15:28.641Z
- SHA-256 of the archived text
a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864- Stable URL of this page
https://metraipolis.com/documento/dc_d1e00fb8e899
How to cite
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328 — Europe PMC (en), https://europepmc.org/article/MED/42435328 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1e00fb8e899 (Metraipolis archive dc_d1e00fb8e899, sha256 a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864)
BibTeX
@misc{dcd1e00fb8e899,
title = {Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42435328},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1e00fb8e899; sha256 a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42435328. Agents can read the archived copy with the MCP tool read_document.